321 related articles for article (PubMed ID: 25149096)
1. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.
Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B
Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096
[TBL] [Abstract][Full Text] [Related]
2. Combine Phage Antibody Display Library Selection on Patient Tissue Specimens with Laser Capture Microdissection to Identify Novel Human Antibodies Targeting Clinically Relevant Tumor Antigens.
Su Y; Bidlingmaier S; Lee NK; Liu B
Methods Mol Biol; 2018; 1701():331-347. PubMed ID: 29116514
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Macropinocytosing Human Antibodies by Phage Display and High-Content Analysis.
Ha KD; Bidlingmaier SM; Su Y; Lee NK; Liu B
Methods Enzymol; 2017; 585():91-110. PubMed ID: 28109445
[TBL] [Abstract][Full Text] [Related]
4. Discovery of internalizing antibodies to tumor antigens from phage libraries.
Zhou Y; Marks JD
Methods Enzymol; 2012; 502():43-66. PubMed ID: 22208981
[TBL] [Abstract][Full Text] [Related]
5. Selection of tumor-specific internalizing human antibodies from phage libraries.
Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
[TBL] [Abstract][Full Text] [Related]
6. Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens.
Zhou Y; Zou H; Zhang S; Marks JD
J Mol Biol; 2010 Nov; 404(1):88-99. PubMed ID: 20851130
[TBL] [Abstract][Full Text] [Related]
7. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.
Su Y; Liu Y; Behrens CR; Bidlingmaier S; Lee NK; Aggarwal R; Sherbenou DW; Burlingame AL; Hann BC; Simko JP; Premasekharan G; Paris PL; Shuman MA; Seo Y; Small EJ; Liu B
JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185663
[TBL] [Abstract][Full Text] [Related]
8. Identification of target and function specific antibodies for effective drug delivery.
Zhou Y; Marks JD
Methods Mol Biol; 2009; 525():145-60, xv. PubMed ID: 19252832
[TBL] [Abstract][Full Text] [Related]
9. Antibody internalization studied using a novel IgG binding toxin fusion.
Mazor Y; Barnea I; Keydar I; Benhar I
J Immunol Methods; 2007 Apr; 321(1-2):41-59. PubMed ID: 17336321
[TBL] [Abstract][Full Text] [Related]
10. Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy.
Yang Y; Nian S; Li L; Wen X; Liu Q; Zhang B; Lan Y; Yuan Q; Ye Y
Bioengineered; 2021 Dec; 12(2):10379-10400. PubMed ID: 34709992
[TBL] [Abstract][Full Text] [Related]
11. Manipulation of Cell-Type Selective Antibody Internalization by a Guide-Effector Bispecific Design.
Lee NK; Su Y; Bidlingmaier S; Liu B
Mol Cancer Ther; 2019 Jun; 18(6):1092-1103. PubMed ID: 30962321
[TBL] [Abstract][Full Text] [Related]
12. Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells.
Hellmann I; Waldmeier L; Bannwarth-Escher MC; Maslova K; Wolter FI; Grawunder U; Beerli RR
Front Immunol; 2018; 9():2490. PubMed ID: 30450096
[TBL] [Abstract][Full Text] [Related]
13. Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection.
Ruan W; Sassoon A; An F; Simko JP; Liu B
Mol Cell Proteomics; 2006 Dec; 5(12):2364-73. PubMed ID: 16982673
[TBL] [Abstract][Full Text] [Related]
14. Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer.
Liu B; Conrad F; Roth A; Drummond DC; Simko JP; Marks JD
J Mol Med (Berl); 2007 Oct; 85(10):1113-23. PubMed ID: 17554518
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.
Goenaga AL; Zhou Y; Legay C; Bougherara H; Huang L; Liu B; Drummond DC; Kirpotin DB; Auclair C; Marks JD; Poul MA
Mol Immunol; 2007 Jul; 44(15):3777-88. PubMed ID: 17498801
[TBL] [Abstract][Full Text] [Related]
16. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
[TBL] [Abstract][Full Text] [Related]
17. The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.
Lund K; Bostad M; Skarpen E; Braunagel M; Kiprijanov S; Krauss S; Duncan A; Høgset A; Selbo PK
MAbs; 2014; 6(4):1038-50. PubMed ID: 24525727
[TBL] [Abstract][Full Text] [Related]
18. Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications.
D'Angelo S; Staquicini FI; Ferrara F; Staquicini DI; Sharma G; Tarleton CA; Nguyen H; Naranjo LA; Sidman RL; Arap W; Bradbury AR; Pasqualini R
JCI Insight; 2018 May; 3(9):. PubMed ID: 29720567
[TBL] [Abstract][Full Text] [Related]
19. Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies.
Shukla GS; Krag DN; Peletskaya EN; Pero SC; Sun YJ; Carman CL; McCahill LE; Roland TA
Cancer Immunol Immunother; 2013 Aug; 62(8):1397-410. PubMed ID: 23736951
[TBL] [Abstract][Full Text] [Related]
20. High throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody libraries.
Hou SC; Chen HS; Lin HW; Chao WT; Chen YS; Fu CY; Yu CM; Huang KF; Wang AH; Yang AS
Sci Rep; 2016 Aug; 6():31878. PubMed ID: 27550798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
